His primary areas of study are Molecular biology, Internal medicine, Cell biology, Endocrinology and Cancer research. His research integrates issues of Cell culture, Cyclin D1, Cyclin A, Monocyte and Umbilical vein in his study of Molecular biology. The Internal medicine study combines topics in areas such as Gastroenterology, Fetal hemoglobin and Immunology.
His studies deal with areas such as Regulation of gene expression and Growth factor as well as Cell biology. His Endocrinology study combines topics in areas such as Endothelial stem cell and Globin. Douglas V. Faller interconnects Transcription factor, Histone deacetylase, Histone, Cell cycle and CpG site in the investigation of issues within Cancer research.
His primary scientific interests are in Molecular biology, Cell biology, Cancer research, Internal medicine and Immunology. His Molecular biology research is multidisciplinary, incorporating perspectives in Cell culture, Gene expression, Virology, Signal transduction and Globin. His Globin study integrates concerns from other disciplines, such as Phenylbutyrate, Fetal hemoglobin and Reporter gene.
His Cell biology research incorporates themes from Endothelial stem cell, Jurkat cells, Cell and Growth factor. His Cancer research research integrates issues from Cell growth, Apoptosis, Cell cycle, Histone deacetylase and Prostate cancer. Douglas V. Faller combines subjects such as Azacitidine, Endocrinology and Oncology with his study of Internal medicine.
His primary areas of investigation include Internal medicine, Myelodysplastic syndromes, Oncology, Myeloid leukemia and Azacitidine. His research in Internal medicine intersects with topics in Gastroenterology and Hypomethylating agent. His research investigates the connection between Oncology and topics such as AL amyloidosis that intersect with issues in Pharmacotherapy.
His work is dedicated to discovering how Myeloid leukemia, Intensive care medicine are connected with Diabetes mellitus and Eye disease and other disciplines. In his study, which falls under the umbrella issue of Azacitidine, Myelogenous, Cancer research, Intensive chemotherapy and Endometrial cancer is strongly linked to Phases of clinical research. His study in the fields of Melanoma under the domain of Cancer research overlaps with other disciplines such as Cytokine release syndrome.
His primary areas of study are Internal medicine, Azacitidine, Myeloid leukemia, Hypomethylating agent and Leukemia. Internal medicine is often connected to Oncology in his work. His Azacitidine study combines topics from a wide range of disciplines, such as Chronic myelomonocytic leukemia and Myelodysplastic syndromes.
Douglas V. Faller has included themes like Healthcare utilization, Chemotherapy, Intensive care unit and Emergency medicine in his Myeloid leukemia study. His work carried out in the field of Hypomethylating agent brings together such families of science as Cytarabine, Randomized controlled trial, Progression-free survival and Retrospective cohort study. His studies in Myelogenous integrate themes in fields like Cancer research, Confidence interval, Phases of clinical research and Performance status.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.
Nancy C. Andrews;Douglas V. Faller.
Nucleic Acids Research (1991)
Hypoxia induces endothelin gene expression and secretion in cultured human endothelium.
S Kourembanas;P A Marsden;L P McQuillan;D V Faller.
Journal of Clinical Investigation (1991)
Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia.
S Kourembanas;L P McQuillan;G K Leung;D V Faller.
Journal of Clinical Investigation (1993)
A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin Disorders
S. P. Perrine;G. D. Ginder;D. V. Faller;G. H. Dover.
The New England Journal of Medicine (1993)
Neutral amino acids in the brain: changes in response to food ingestion.
John D. Fernstrom;Douglas V. Faller.
Journal of Neurochemistry (1978)
Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells.
S Kourembanas;R L Hannan;D V Faller.
Journal of Clinical Investigation (1990)
Endothelial cell responses to hypoxic stress.
Douglas V Faller.
Clinical and Experimental Pharmacology and Physiology (1999)
Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease.
George F. Atweh;Millicent Sutton;Imad Nassif;Vassiliki Boosalis.
SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis
V Byles;L Zhu;J D Lovaas;L K Chmilewski.
A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.
Susan P. Perrine;Olivier Hermine;Trudy Small;Felipe Suarez.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: